We are live on
!
Find out more
EVLO
Evelo Biosciences, Inc. Common Stock
EVLO
EVLO
Delisted
EVLO was delisted on the 11th of December, 2023.
66 hedge funds and large institutions have $645M invested in Evelo Biosciences, Inc. Common Stock in 2021 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 27 increasing their positions, 16 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
69% more repeat investments, than reductions
Existing positions increased: 27 | Existing positions reduced: 16
63% more first-time investments, than exits
New positions opened: 13 | Existing positions closed: 8
43% more call options, than puts
Call options by funds: $607K | Put options by funds: $424K
27% more capital invested
Capital invested by funds: $508M → $645M (+$137M)
6% more funds holding
Funds holding: 62 → 66 (+4)
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
Holders
66
Holders Change
+4
Holders Change %
+6.45%
% of All Funds
1.15%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.07%
New
13
Increased
27
Reduced
16
Closed
8
Calls
$607K
Puts
$424K
Net Calls
+$183K
Net Calls Change
+$351K
Top Buyers
| 1 |
BlackRock
New York
|
+$2.7M |
| 2 |
State Street
Boston,
Massachusetts
|
+$2.12M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.56M |
| 4 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$1.35M |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$1.09M |
Top Sellers
| 1 |
APM
Avidity Partners Management
Dallas,
Texas
|
-$8.56M |
| 2 |
Invesco
Atlanta,
Georgia
|
-$1.76M |
| 3 |
Marshall Wace
London,
United Kingdom
|
-$1.1M |
| 4 |
Millennium Management
New York
|
-$937K |
| 5 |
CCM
CAAS Capital Management
New York
|
-$883K |
